IMAX

• None no insider bought on the open market
• $34.2M sold by 9 insiders outside a trading plan
• $40.4M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Robert D Lister Chief Legal Officer Sr Exec VP
   Sale
   $1.2M 22,500 shares at $51.58 11% of stake
   Traded Sep 10 Filed Sep 11
   ↗
3. Mark Welton President IMAX Global Theatres
   Sale
   $1.6M 30,000 shares at $54.47 17% of stake
   Traded Aug 25 Filed Aug 26
   ↗
4. Kenneth Ian Weissman Deputy GC, Corp. Sec. & CCO
   Sale
   $436K 8,000 shares at $54.54 22% of stake
   Traded Aug 25 Filed Aug 26
   ↗
5. Natasha Fernandes CFO
   Sale
   $1.1M 20,000 shares at $54.63 36% of stake
   Traded Aug 24 Filed Aug 26
   ↗
6. Calamera Pablo CTO & EVP
   Sale
   $786K 15,000 shares at $52.41 26% of stake
   Traded Aug 20 Filed Aug 21
   ↗
7. Richard L Gelfond CEO
   Planned sale
   $24M 456,757 shares at $52.51 41% of stake
   Traded Aug 18–20 Filed Aug 20
   ↗
8. Jose Aleksandr Zlatar SVP, Controller & PAO
   Sale
   $25K 500 shares at $49.90 46% of stake
   Traded Aug 6 Filed Aug 7
   ↗
9. Richard L Gelfond CEO
   Planned sale
   $334K 8,943 shares at $37.33 1.2% of stake
   Traded Apr 27 Filed Apr 28
   ↗
10. Richard L Gelfond CEO
    Planned sale
    $2.8M 75,919 shares at $37.05 9% of stake
    Traded Apr 16–17 Filed Apr 20
    ↗
11. Richard L Gelfond CEO
    Planned sale
    $4.5M 120,132 shares at $37.14 14% of stake
    Traded Apr 13–15 Filed Apr 15
    ↗
12. Richard L Gelfond CEO
    Planned sale
    $5.1M 135,046 shares at $37.82 15% of stake
    Traded Apr 10 Filed Apr 10
    ↗
13. Richard L Gelfond CEO
    Planned sale
    $1M 25,024 shares at $40.14 3.2% of stake
    Traded Apr 2–6 Filed Apr 6
    ↗
14. Kevin Douglas Director, +2 joint filers
    Sale
    $21.5M 568,000 shares at $37.82
    Traded Mar 16 Filed Mar 17
    ↗
15. Richard L Gelfond CEO
    Sale
    $4.9M 121,220 shares at $40.10 14% of stake
    Traded Mar 10 Filed Mar 12
    ↗
16. Mark Welton President IMAX Global Theatres
    Planned sale
    $982K 25,000 shares at $39.28 16% of stake
    Traded Dec 15, 2025 Filed Dec 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 39 option exercises, 25 share withholdings for taxes, 16 conversions, 13 stock grants, and 2 gifts.